Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,800
+600 (4.55%)
At close: Jan 30, 2026

Cell Biotech Revenue

Cell Biotech had revenue of 15.36B KRW in the quarter ending September 30, 2025, with 26.25% growth. This brings the company's revenue in the last twelve months to 50.65B, down -3.71% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.

Revenue (ttm)
50.65B
Revenue Growth
-3.71%
P/S Ratio
1.78
Revenue / Employee
501.47M
Employees
101
Market Cap
90.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202449.91B-3.87B-7.20%
Dec 31, 202353.79B3.26B6.46%
Dec 31, 202250.53B3.65B7.79%
Dec 31, 202146.87B1.29B2.83%
Dec 31, 202045.58B-377.42M-0.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CTCBIO132.76B
KoBioLabs71.83B
Choong Ang Vaccine Laboratory39.19B
Naturalendo Tech21.87B
PanGen Biotech15.27B
HLB Pep4.89B
Quratis2.28B
Progen450.00M
Revenue Rankings